The anti hypertensive drugs market is evolving beyond single-agent therapy towards more sophisticated, personalized approaches that address the complex pathophysiology of hypertension. As clinicians recognize that high blood pressure often involves multiple mechanisms—renin-angiotensin activation, sodium retention, sympathetic overactivity—the demand for combination therapies and...